The current technology presents an ultra-rapid test for determining antibiotic sensitivity of pathogens found in human urine leading to uti. this novel technology, developed by us, replicates the basic tenets of clinical microbiology, namely 1) growth of bacteria in a specialized medium and 2) measuring the inhibition of growth of bacteria in the presence of an antibiotic. detection is based on chromogenic endpoints which are measured using a set of optical sensors. the output is analyzed using lab-developed algorithm based software which reports the sensitivity of the pathogen to the panel of antibiotics tested. the display on the screen shows the results in terms of sensitivity, moderate sensitivity or resistance to any given antibiotic. sensitivity and specificity of the new test for measuring antibiotic susceptibility was found to be 0.94 and 0.97, respectively. the results of ast using the new test are available in 3 hours as compared to 48-72 hours taken for conventional culture results (based on kirby-baeur disc method). availability of this rapid assay will completely obliterate the need for empirical treatment in case of uti and lead to specific and most appropriate treatment at the earliest. the components of the technology include: • in-house developed medium (bitgen) for rapid growth of uropathogens. • a specially fabricated readout device, which gives an alphanumeric display on a lcd screen. • pre-functionalized panel in strip format allowing screening for multiple antibiotics.